ORCID "0000-0003-1018-1119" Tıp Fakültesi Koleksiyonu için listeleme
-
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
Bilgin, Burak; Sendur, Mehmet Ali; Yücel, Şebnem; Çelik, Emir; Özyükseler, Deniz Tataroğlu; Ayhan, Murat; Yalçın, Bülent; Avcı, Okan (Springer, 2021)Background The new second-generation tyrosine kinase inhibitors (TKIs) have superior survival outcome and worse toxicity profile when compared with first-generation TKIs according to the results of clinical trials. However, ... -
Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
Özgün, M. A.; Doğan, I.; Karakurt Eryılmaz, Melek; Erdoğan, A. P.; Ayhan, M.; Hafızoğlu, E.; Laçin, S.; Çavdar, Eyyüp (Elsevier, 2021)[No Abstract Available]